INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

PHASE2CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

April 30, 2014

Conditions
AMDWet AMDAge-Related Macular DegenerationWet Age-Related Macular DegenerationMacular DegenerationEye DiseasesRetinal Diseases
Interventions
DEVICE

IRay

Low voltage stereotactic radiotherapy system

Trial Locations (21)

17036

Klinik für Augenheilkunde, Neubrandenburg

69120

Kopfklinikum University Hospital Heidelberg, Heidelberg

72076

University Eye Hospital, Tübingen

A-8036

LKH Graz, Graz

A-6020

Universitätsklinik Innsbruck, Innsbruck

A-1140

Hanusch Krankenhaus Wien, Vienna

A-1180

Ordination Prof. Michael Stur, Vienna

625 00

Fakultni Nemocnice Brno, Brno

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

775 20

Fakultni Nemocnice Olomouc, Olomouc

100 34

Faculty Hospital Kralovske Vinohrady, Prague

128 08

General Faculty Hospital Prague, Prague

169 02

Military Hospital Prague, Prague

I-20132

Università Vita-Salute Istituto Scientifico San Raffaele, Milan

BT12 6BA

Royal Victoria Hospital, Belfast

BDP 6RJ

Bradford Royal Infirmary, Bradford

TQ2 7AA

Torbay Hospital, Devon

SE5 9RS

King's College, London

M13 9WL

Manchester Royal Eye Hospital, Manchester

SO16 6YD

Southampton General Hospital, Southampton

WV3 9QR

Royal Wolverhampton Hospital NHS Foundation Trust, Wolverhampton

Sponsors
All Listed Sponsors
lead

Oraya Therapeutics, Inc.

INDUSTRY